View Document Preview and Link
Open Document File Size: 251 B Share Result on Facebook
Company Takeda Pharmaceuticals America Inc. / Takeda Pharmaceuticals / Inc. / / Event FDA Phase / Product Issues / / Facility Laboratory Test Interactions ROZEREM / Laboratory Test Interactions / Laboratory Tests Monitoring No / Poison Control Center / A laboratory / Laboratory Tests ROZEREM / / IndustryTerm treatment of insomnia / machinery / food / heavy machinery / chemical / / MedicalCondition medical illness / severe sleep apnea / central apnea / COPD / headache / obstructive sleep apnea / galactorrhea / hallucinations / nausea / anaphylaxis / angioedema involving / additive psychomotor impairment / severe COPD / exacerbated insomnia / fatigue / physical disorder / chronic insomnia / Concomitant Illness / insomnia / airway obstruction / dyspnea / Amnesia / Carcinogenesis / Chronic Obstructive Pulmonary Disease / chronic intermittent use / chronic / mania / Apnea / psychiatric disorder / vomiting / Sleep Apnea / angioedema / dizziness / Depression / / MedicalTreatment Hemodialysis / dialysis / / Organization Oral administration / DOSAGE AND ADMINISTRATION / FDA / / / Position General / Major / / Product venlafaxine / Luvox / escitalopram / ROZEREM / polyethylene glycol / omeprazole / albuterol / RAM / Rifampin / Fluconazole / diazepam / fluoxetine / theophylline / digoxin / gabapentin / testosterone / Donepezil / Ketoconazole / dimethyl sulfoxide / zolpidem / activities / / Technology RAM / drug screening / Pharmacokinetics / dialysis / / URL www.fda.gov/medwatch / / SocialTag